{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T04:16:35Z","timestamp":1769746595584,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY14H160010"],"award-info":[{"award-number":["LY14H160010"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2017194140"],"award-info":[{"award-number":["2017194140"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ygyno.2021.04.005","type":"journal-article","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T04:42:34Z","timestamp":1618288954000},"page":"50-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Different prognosis of stage IIIB cervical cancer patients with lower third of vaginal invasion and those without"],"prefix":"10.1016","volume":"162","author":[{"given":"Chenyan","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aijun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiejie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2021.04.005_bb0005","series-title":"GLOBOCAN 2012 [Internet]. Version 1.0. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon (France)","author":"Ferlay","year":"2016"},{"key":"10.1016\/j.ygyno.2021.04.005_bb0010","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/S0140-6736(03)13778-6","article-title":"Cervical cancer","volume":"361","author":"Waggoner","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2021.04.005_bb0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2021.04.005_bb0020","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1002\/1097-0142(19910601)67:11<2776::AID-CNCR2820671111>3.0.CO;2-L","article-title":"Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group","volume":"67","author":"Stehman","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2021.04.005_bb0025","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ijgo.12611","article-title":"Cancer of the cervix uteri","volume":"143","author":"Bhatla","year":"2018","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2021.04.005_bb0030","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ijrobp.2004.03.035","article-title":"IMRT dose escalation for positive Para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk","volume":"60","author":"Ahmed","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2021.04.005_bb0035","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1200\/JCO.2004.07.197","article-title":"Pelvic irradiation with concurrent chemotherapy versus pelvic and Para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01","volume":"22","author":"Eifel","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2021.04.005_bb0040","author":"National Institutes of Health"},{"key":"10.1016\/j.ygyno.2021.04.005_bb0045","article-title":"Comparing treatment outcomes of stage IIIB cervical cancer patients between those with and without lower third of vaginal invasion","volume":"28","author":"Kanyarat","year":"2017","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.04.005_bb0050","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/jamaoncol.2017.5078","article-title":"Concurrent chemoradiotherapy for stage IIIB cervical cancer-global impact through power","volume":"4","author":"Nwachukwu","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ygyno.2021.04.005_bb0055","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jfma.2012.10.021","article-title":"The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy","volume":"114","author":"Chen","year":"2015","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.ygyno.2021.04.005_bb0060","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ygyno.2010.01.045","article-title":"Impact of hydronephrosis on outcome of stage IIIB cervical cancer patients with disease limited to the pelvis, treated with radiation and concurrent chemotherapy: a gynecologic oncology group study","volume":"117","author":"Rose","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.04.005_bb0065","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.7314\/APJCP.2015.16.10.4219","article-title":"Effect of Hydronephrosis on survival in advanced stage cervical Cancer","volume":"16","author":"G\u00f6kl\u00fc","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.ygyno.2021.04.005_bb0070","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3892\/etm_00000102","article-title":"Neoadjuvant intraarterial chemotherapy for stage IIB\u2013IIIB cervical cancer in Japanese women","volume":"1","author":"Kaku","year":"2010","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ygyno.2021.04.005_bb0075","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1006\/gyno.2000.5730","article-title":"Neoadjuvant intraarterial infusion chemotherapy in patients with stage IB2-IIIB cervical cancer","volume":"77","author":"Yamakawa","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.04.005_bb0080","series-title":"Perez and Brady\u2019s principles and practice of radiation oncology","first-page":"1532","author":"Perez","year":"2008"},{"key":"10.1016\/j.ygyno.2021.04.005_bb0085","first-page":"706","article-title":"Thromboembolic event as a prognostic factor for the survival of patients with stage IIIB cervical cancer","volume":"21","author":"Renni","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2021.04.005_bb0090","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000273207","article-title":"Concurrent weekly nedaplatin, external beam radiotherapy and high-dose-rate brachytherapy in patients with FIGO stage IIIb cervical cancer: a comparison with a cohort treated by radiotherapy alone","volume":"69","author":"Mabuchi","year":"2010","journal-title":"Gynecol. Obstet. Investig."},{"key":"10.1016\/j.ygyno.2021.04.005_bb0095","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/jrr\/rrs010","article-title":"Impact of concurrent chemotherapy on definitive radiotherapy for women with FIGO IIIb cervical cancer","volume":"53","author":"Yuuki","year":"2012","journal-title":"J. Radiat. Res."},{"key":"10.1016\/j.ygyno.2021.04.005_bb0100","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ijrobp.2004.03.035","article-title":"IMRT dose escalation for positive Para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk","volume":"60","author":"Ahmed","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821002754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821002754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:55:53Z","timestamp":1758772553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821002754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0090825821002754"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.04.005","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Different prognosis of stage IIIB cervical cancer patients with lower third of vaginal invasion and those without","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}